(Adds background on AT1 instruments and similar issues by other banks, pars 1,3-4. Shortens headline)
Commonwealth Bank of Australia (CBA) on Wednesday doubled an AT1 hybrid security offering to A$1.55 billion ($1.05 billion) and closed book building for the issue six days ahead of schedule in a sign of appetite for the instruments written to zero during the Credit Suisse takeover.
Commonwealth Bank allocated A$1.55 billion of the CommBank PERLS XVI Capital Notes, according to a statement on Wednesday, up from the A$750 million flagged when the prospectus launched a day earlier.
The issue by Australia's biggest bank follows a
$1 billion issue
by Japan's Sumitomo Mitsui Financial Group 8316.T in April as banks tentatively return to a market rocked during the government-brokered takeover of Credit Suisse by rival UBS Group AG UBSG.S in March.
The Swiss regulator ruled that holders of more than $17 billion worth of Credit Suisse AT1s received nothing in the deal despite shareholders, who sit below bondholders on the priority ladder for repayment in a bankruptcy process, receiving more than $3 billion.
The first issue by a major Australian bank since then, book building had originally been scheduled to run until 23 May.
The margin was set at 3% per annum above the Bank Bill Swap Reference Rate, the lower end of the 3% to 3.2% range floated in the prospectus.
- Forums
- ASX - By Stock
- CBA
- News: CBA UPDATE 1-Commonwealth Bank doubles AT1 issue to $1 billion, closes bookbuilding early
CBA
commonwealth bank of australia.
Add to My Watchlist
2.81%
!
$185.36

News: CBA UPDATE 1-Commonwealth Bank doubles AT1 issue to $1 billion, closes bookbuilding early
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$185.36 |
Change
-5.350(2.81%) |
Mkt cap ! $310.1B |
Open | High | Low | Value | Volume |
$190.50 | $191.06 | $185.36 | $367.6M | 1.971M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4521 | $185.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$185.88 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 29 | 185.360 |
1 | 1876 | 185.330 |
1 | 2151 | 185.230 |
1 | 2070 | 185.140 |
1 | 2166 | 185.050 |
Price($) | Vol. | No. |
---|---|---|
185.880 | 70 | 1 |
186.090 | 50 | 1 |
186.510 | 122 | 1 |
186.680 | 1510 | 1 |
186.820 | 100 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
CBA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online